Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine versus placebo after primary angioplasty in STEMI
IRCT20120215009014N615Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Colchicine plus routine care with Placebo plus routine care (2 arms). Primary endpoints: Number of ischemic segments, Left ventricular output and 3 more. Started Jul 2026; status: completed.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20120215009014N615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N615.